A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
Condition: Dwarfism Intervention: Drug: Recombinant Human Growth Hormone Injection (rhGH) Sponsors: GeneScience Pharmaceuticals Co., Ltd.; Children's Hospital of Fudan University; Beijing Children's Hospital; Children's Hospital of Shanghai; Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; The Children's Hospital, Zhejiang University S chool Of Medicine; Children's hospital capital institute of pediatrics; Peking University First Hospital; Fuzhou General Hospital; The First Affiliated Hospital of Zhengzhou University; Shengjing Hospital; Children's Hospital of Chongqing Medical University; Tongji medical college huazhong university of science& technology Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Chronic Kidney Disease | Hormones | Hospitals | Kidney Transplant | Kidney Transplantation | Pediatrics | Research | Science | Study | Transplants | Urology & Nephrology